Skip to content

Construction of clinical accurate diagnosis and treatment system for necrotizing soft tissue infection

Construction of clinical accurate diagnosis and treatment system for necrotizing soft tissue infection

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048907
Enrollment
Unknown
Registered
2021-07-19
Start date
2021-07-15
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Necrotizing soft tissue infection

Interventions

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for subjects with necrotizing soft tissue infection (NSTI) (high clinical suspicion of NSTI + surgical incision): (1) High clinical suspicion of NSTI: 1) Laboratory indicator risk prediction (LRINEC): NSTI should be suspected with a score of 6 to 8, and a score >= 8 is highly predictive of NSTI. 2) Positive finger test: the diseased fascia is no longer closely attached to the adjacent tissue layer, and the operator's finger is easy to slide along the fascia plane. (2) Surgical incision: gray-white necrotic tissue, fascial edema, thrombosis, foul-smelling exudate, watery exudate, no muscle contraction, and easy separation of superficial and superficial fascia all indicate subcutaneous tissue necrosis. 2. Non-NSTI inclusion criteria: subjects with skin/soft tissue infection who do not meet the NSTI criteria. 3. Enrollment criteria for healthy subjects: age matched with NSTI and non-NSTI, no diabetes, hypertension, coronary heart disease, tumor, liver, kidney and autoimmune diseases and other diseases.

Exclusion criteria

Exclusion criteria: 1. Aged < 18 years; 2. Patients with hospital stay less than 12 hours and incomplete clinical data; 3. Patients unwilling to sign informed consent.

Design outcomes

Primary

MeasureTime frame
metabolite;gene(RIP3);

Countries

China

Contacts

Public ContactLu Zhongqiu

The First Affiliated Hospital of Wenzhou Medical University

352368881@qq.com+86 13957759958

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026